ARCHIVES

Telatinib Demonstrates Positive Results in First-Line Treatment

This article is from The Cancer Letter archive.

Vol. 34 No. 6 | June 24, 2011

Download PDF Visit The Full Archive

Related Articles

FDA Hears More Criticism On Cancer Drug Endpoints; Joint Conferences On Criteria Recommended

July 28, 1989

Overdiagnosis Since Advent Of Prostate Cancer Screening

September 25, 2009

In Brief: GM Prizes: Einhorn, McMahon, Nusslein-Volhard; James, Poznanski Lead Roentgen Ray Society

June 26, 1992

ACCC Enthusiastically Support New Effort Or Clinical Research

April 3, 1981

NCAB Urges Reprogramming If Needed To Assure $150 Million For Construction Through FY 1985

June 8, 1979

No Protective Effect From Long-Term Vitamin E or C

November 28, 2008